EP1051499A2 - Polypeptides et polynucleotides de tyrosylproteine-sulfotransferases - Google Patents
Polypeptides et polynucleotides de tyrosylproteine-sulfotransferasesInfo
- Publication number
- EP1051499A2 EP1051499A2 EP99904344A EP99904344A EP1051499A2 EP 1051499 A2 EP1051499 A2 EP 1051499A2 EP 99904344 A EP99904344 A EP 99904344A EP 99904344 A EP99904344 A EP 99904344A EP 1051499 A2 EP1051499 A2 EP 1051499A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- seq
- polynucleotide
- tpst
- bases
- tyrosylprotein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/13—Transferases (2.) transferring sulfur containing groups (2.8)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
Definitions
- Antibodies generated against the polypeptides corresponding to a sequence of the present invention can be obtained by direct injection of the polypeptides into an animal or by other appropriate forms of administering the polypeptides to an animal, preferably a nonhuman. The antibody so obtained will then bind the polypeptides itself. In this manner, even a sequence encoding only a fragment of the polypeptides can be used to generate antibodies binding the whole native polypeptides. Such antibodies can then be used to isolate the polypeptide from tissue expressing that polypeptide.
- Bound protein was eluted with 10 mM EDTA, 0.15 M NaCl, 20 mM MOPS (pH 7.5), 0.1% Triton X-100. Fractions were assayed for protein content and TPST activity. Samples were electrophoresed on 10% SDS polyacrylamide gels and proteins transferred to Hybond-P membranes (Amersham) . The membranes were blocked, probed with HPC4, and bound antibody detected with enhanced chemiluminescence using horseradish peroxidase-conjugated anti-mouse immunoglobulin (Amersham) .
- Base homologies of the various TPST gene core sequences are shown in Table VIII.
- the core sequences of human and mouse TPST-1 have 90% homology (identity) .
- Human and mouse TPST-2 gene core sequences have 90% homology.
- Human TPST-A and TPST-B gene core sequences have 59% homology.
- Human TPST-1 and TPST-2 gene core sequences have 68% homology.
- Mouse TPST-1 and TPST-2 gene core sequences have 69% homology.
- Human TPST-1 and mouse TPST-2 gene core sequences have 67% homology.
- Human TPST-2 and mouse TPST-1 gene core sequences have 67% homology.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
L'invention concerne des tyrosylprotéine-sulfotransférases et des acides nucléiques codant ces tyrosylprotéine-sulfotransférases. On a identifié chez l'homme, la souris, et C. elegans des isotopes doubles de l'enzyme et des acides nucléiques codant ces enzymes. Ces polypeptides et polynucléotides présentent une gamme étendue d'homologies. Les polynucléotides peuvent être utilisés pour transformer ou transfecter des cellules hôtes afin de produire des formes sensiblement pures de l'enzyme, ou dans un système d'expression destiné à la sulfatation post-translationnelle de la tyrosine de protéines et de peptides produits dans ce système d'expression.
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7299498P | 1998-01-29 | 1998-01-29 | |
| US72994P | 1998-01-29 | ||
| US09/150,133 US6060295A (en) | 1998-01-29 | 1998-09-09 | Nucleic acids and expression systems encoding tyrosylprotein sulfo transferases |
| US09/150,141 US6071732A (en) | 1998-01-29 | 1998-09-09 | Tyrosylprotein sulfotransferases, nucleic acids encoding tyrosylprotein sulfotransferases, and methods of use thereof |
| US150141 | 1998-09-09 | ||
| US150133 | 1998-09-09 | ||
| PCT/US1999/001756 WO1999038980A2 (fr) | 1998-01-29 | 1999-01-28 | Polypeptides et polynucleotides de tyrosylproteine-sulfotransferases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1051499A2 true EP1051499A2 (fr) | 2000-11-15 |
Family
ID=27372205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP99904344A Withdrawn EP1051499A2 (fr) | 1998-01-29 | 1999-01-28 | Polypeptides et polynucleotides de tyrosylproteine-sulfotransferases |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1051499A2 (fr) |
| AU (1) | AU2475899A (fr) |
| WO (1) | WO1999038980A2 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0008326D0 (en) * | 2000-04-06 | 2000-05-24 | Shs International Ltd | Diagnosis and treatment of autism and related disorders |
| US7306923B2 (en) | 2004-06-14 | 2007-12-11 | Galapagos N.V. | Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases |
-
1999
- 1999-01-28 EP EP99904344A patent/EP1051499A2/fr not_active Withdrawn
- 1999-01-28 AU AU24758/99A patent/AU2475899A/en not_active Abandoned
- 1999-01-28 WO PCT/US1999/001756 patent/WO1999038980A2/fr not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO9938980A3 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999038980A9 (fr) | 1999-10-21 |
| AU2475899A (en) | 1999-08-16 |
| WO1999038980A3 (fr) | 2000-03-30 |
| WO1999038980A2 (fr) | 1999-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7575885B2 (en) | Tyrosylprotein sulfotransferases and methods of use thereof | |
| Bierhuizen et al. | Expression cloning of a cDNA encoding UDP-GlcNAc: Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen. | |
| Lam et al. | Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4. | |
| JP3136551B2 (ja) | インターロイキン1β前駆体変換酵素をコードするDNA | |
| US5457182A (en) | FK-506 cytosolic binding protein, FKBP12.6 | |
| AU706747B2 (en) | Antibody specific for beta1->6N- acetylglucosamininyltransferase | |
| US6071732A (en) | Tyrosylprotein sulfotransferases, nucleic acids encoding tyrosylprotein sulfotransferases, and methods of use thereof | |
| Humphries et al. | Localization of human heparan glucosaminyl N-deacetylase/N-sulphotransferase to the trans-Golgi network | |
| US6713283B2 (en) | Tyrosylprotein sulfotransferases | |
| US6492152B1 (en) | Core 1 β3-galactosyl transferases and methods of use thereof | |
| US6207414B1 (en) | Tyrosylprotein sulfotransferases and methods of use thereof | |
| US6461835B1 (en) | Fucosyltransferases, polynucleotides encoding fucosyltransferases, and transgenic mammal incorporating same | |
| US6204016B1 (en) | Tyrosylprotein sulfotransferases and methods of use thereof | |
| US6207432B1 (en) | Tyrosylprotein sulfotransferases and methods of use thereof | |
| CA2335436A1 (fr) | Nouveaux genes noyaux 2 beta-1,6-n-acetylgylcosaminyltransferase | |
| US6605455B1 (en) | Tyrosylprotein sulfotransferases and methods of use thereof | |
| WO1999038980A2 (fr) | Polypeptides et polynucleotides de tyrosylproteine-sulfotransferases | |
| US6060295A (en) | Nucleic acids and expression systems encoding tyrosylprotein sulfo transferases | |
| WO2000014250A1 (fr) | Polypeptides de tyrosylproteine sulfotransferase et polynucleotides | |
| US20030235884A1 (en) | Polynucleotides encoding core 1 beta3-galactosyl transferase and methods of use thereof | |
| US7273754B2 (en) | Core 1 β3-galactosyltransferase specific molecular chaperones, nucleic acids, and methods of use thereof | |
| US20040086995A1 (en) | Beta1, 4-N-Acetylgalactosaminyltransferases, nucleic acids and methods of use thereof | |
| US20030059915A1 (en) | Core 1 beta3-galactosyl transferases and methods of use thereof | |
| EP1240334A2 (fr) | $g(b)3-galactosyle transferases de coeur 1 et procedes d'utilisation associes | |
| US6994996B1 (en) | Polypeptide, human vacuolar H+ -ATPase C subunit 42 and polynucleotide encoding it |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20000829 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| 17Q | First examination report despatched |
Effective date: 20030620 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20031231 |